Stories of Covid vaccination side effects or worse

[Antony]

@Aeneas, deepest regrets
I am still overwhelmed by seeing the necrology of my colleague in the office. Suddenly at the age of 39 he passed away. The day before we normally went smoking/talking. He took 3 jabs during and after plandemic and wore the mask till 2022. The cause of death was blood cloth.

 

[meadow_wind]

View attachment 104415

That is damn scary how are we going to protect ourselves? We know there are protocols of dissolving that chip crap inside, but still…

Anthony, this site (people's voice) publishes disinformation (as confirmed by other members):

'The People's Voice' is a known disinformation site, essentially fake news. There are CIA connections too.

These might be more reliable in terms of info:

Rise of the RNA machines – self-amplification in mRNA vaccine design - PMC

mRNA vaccines have won the race for early COVID-19 vaccine approval, yet improvements are necessary to retain this leading role in combating infectious diseases. A next generation of self-amplifying mRNAs, also known as replicons, form an ideal ...

pmc.ncbi.nlm.nih.gov

A next generation of self-amplifying mRNAs, also known as replicons, form an ideal vaccine platform. Replicons induce potent humoral and cellular responses with few adverse effects upon a minimal, single-dose immunization. Delivery of replicons is achieved with virus-like replicon particles (VRPs), or in nonviral vehicles such as liposomes or lipid nanoparticles. Here, we discuss innovative advances, including multivalent, mucosal, and therapeutic replicon vaccines, and highlight novelties in replicon design.

Replicating RNA vaccine confers durable immunity against Crimean Congo hemorrhagic fever virus challenge in mice - npj Vaccines

Spread by Hyalomma genus ticks, Crimean-Congo hemorrhagic fever virus (CCHFV) causes a severe hemorrhagic disease endemic throughout Southern and Eastern Europe, Asia, and Africa. To date, there are no widely approved vaccines for CCHFV and treatment for disease is largely supportive. Due to...

www.nature.com

COVID-19 Self-Amplifying mRNA Injection Nears European Approval

CHMP recommends authorization despite grave safety concerns; final regulatory approval now rests with the European Commission.

substack.com

On December 12, 2024, the Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion recommending marketing authorization for Kostaive, a self-replicating (replicon) mRNA injection developed by Arcturus Therapeutics. The final decision for regulatory approval now rests with the European Commission
(...)
During the clinical trials for Kostaive, five deaths were reported among participants in the phase 3b study. Across study phases 1, 2, and 3a combined, 90% of injected participants experienced adverse events, with 74.5% reporting systemic reactions and 15.2% requiring medical attention after the first dose. Notably, many of the study authors are full-time employees of Arcturus Therapeutics, raising concerns about bias in their conclusions.

Nicolas Hulscher, MPH
Epidemiologist and Foundation Administrator, McCullough Foundation
www.mcculloughfnd.org